I-European Scientific Committee on Consumer Safety (SCCS) isandul’ ukukhupha iimbono zangaphambili ngokhuseleko lwe-ethylhexyl methoxycinnamate (EHMC) esetyenziswa kwizinto zokuthambisa. I-EHMC sisihluzo se-UV esisetyenziswa ngokuqhelekileyo, sisetyenziswa kakhulu kwiimveliso ze-sunscreen.
Izigqibo eziphambili zilandelayo: I-1 SCCS ayikwazi ukugqiba ukuba ukusetyenziswa kwe-EHMC kwi-concentration ephezulu ye-10% kwi-cosmetics ikhuselekile. Isizathu kukuba idatha ekhoyo ayanelanga ukulawula i-genotoxicity yayo. Kukho ubungqina obubonisa ukuba i-EHMC inomsebenzi ophazamisayo we-endocrine, kubandakanywa umsebenzi obalulekileyo we-estrogenic kunye nomsebenzi obuthathaka we-anti androgenic kuzo zombini i-vivo kunye ne-in vitro experiments izinto zokuthambisa. I-SCCS ibonise ukuba olu vavanyo aluzange lubandakanye impembelelo yokhuseleko lwe-EHMC kwindalo.
Ulwazi lwangasemva: I-EHMC okwangoku ivunyelwe ukuba isetyenziswe njenge-sunscreen kwimimiselo ye-EU yezimonyo, kunye noxinzelelo olukhulu lwe-10%. I-EHMC ifunxa kakhulu i-UVB kwaye ayinakukhusela kwi-UVA. I-EHMC inamashumi eminyaka ende yembali yokusetyenziswa, emva kokuba idlule ukuhlolwa kokhuseleko kwi-1991, 1993, kunye ne-2001. Ngo-2019, i-EHMC ifakwe kuluhlu lovavanyo oluphambili lwe-EU lwe-28 enokubakho ukuphazamiseka kwe-endocrine.
Uluvo lwangaphambili lucelwa ngoku esidlangalaleni ukuba lunike izimvo, kunye nomhla wokugqibela we-17 kaJanuwari 2025. I-SCCS iya kuvavanya ngokusekelwe kwimpendulo kwaye ikhuphe uluvo lokugqibela kwixesha elizayo.
Olu luvo lunokuchaphazela imigaqo yokusetyenziswa kwe-EHMC kwi-EU cosmetics. U-Biwei ucebisa ukuba amashishini afanelekileyo kunye nabathengi kufuneka babeke iliso elibukhali inkqubela elandelayo.
Ixesha lokuposa: Nov-20-2024
